OTC · CLCS
Cell Source, Inc.
$0.53+$0.06 (+13.97%)
Cell Source, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.45% below the high.
Loading market information…
OTC · HSITF · USD
Stock price, dividends
Quote as of Jan 14, 2026, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Hadasit Bio-Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 7.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Hadasit Bio-Holdings Ltd, an Israeli biotechnology enterprise established in Jerusalem in 2005, focuses its efforts on critical therapeutic domains. These include oncology, regenerative medicine, and inflammatory diseases. A key offering is ProtAb, an immunotherapeutic monoclonal antibody engineered to treat autoimmune inflammatory disorders.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.53+$0.06 (+13.97%)
Cell Source, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.45% below the high.
$0.04+$0.01 (+33.33%)
CareView Communications, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.31+CA$0.02 (+5.08%)
Telescope Innovations Corp.’s quoted price sits in the lower half of its reported 52-week range, 71.82% below the high.
$0.03$0.00 (0.0%)
Quest PharmaTech Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.23% below the high.
$2.11$0.00 (0.0%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.35% below the high.
$0.00$0.00 (0.0%)
Institute of Biomedical Research Corp.’s quoted price sits in the lower half of its reported 52-week range, 90.36% below the high.
$0.05$0.00 (0.0%)
Gemina Laboratories Ltd.’s quoted price sits in the lower half of its reported 52-week range, 85.46% below the high.
$0.00-$0.01 (-84.0%)
Zenith Capital Corp.’s quoted price sits in the lower half of its reported 52-week range, 99.47% below the high.
